PAUL STANLEY TLUCEK (MD) – Retina Specialist (Ophthalmology) Physician, NPI 1982800470
Retina Specialist (Ophthalmology) Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
343 OPHTHALMOLOGY in OR
Provider Addresses for PAUL STANLEY TLUCEK (MD)
5440 SW WESTGATE DR STE 217
PORTLAND, OR 972212421
Phone: (503) 274-2121
Fax: (866) 843-7990
Type: Location
Northwest Lovejoy Street, Pearl District, Portland, Metro, Multnomah County, Oregon, 97208, United States
PORTLAND, OR 972102861
Phone: (503) 274-2121
Fax: (503) 274-2947
Type: Mailing
4225 NE ST JAMES RD
VANCOUVER, WA 986632148
Phone: (503) 274-2121
Fax: (866) 843-7990
Type: Mailing
2525 NW LOVEJOY ST STE 300
PORTLAND, OR 972102864
Phone: (503) 274-2121
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 6 Open Payments records for all available years, with a total value of $1,229.
Total Amount is formed as General ($1,229) + Research ($0) + Ownership ($0) = $1,229.
Last reported payment date: 2024-11-12 • Largest payer in this snapshot: Novartis Pharmaceuticals Corporation ($908).
Total Amount
$1,229
General + Research + Ownership
Payments
6
Total payment records
General Amount
$1,229
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-11-12
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Novartis Pharmaceuticals Corporation | $908 |
| Regeneron Pharmaceuticals, Inc. | $196 |
| Genentech USA, Inc. | $125 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2013-07-17
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking 2 Medicare enrollment records; no due dates published yet.
Enrollment records
2
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20130717000534 | I | Ophthalmology | WA | TBD |
| I20130717000662 | I | Ophthalmology | OR | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 3,660 | 15 | $0 |
| 92134 | Imaging of retina | 1,666 | 456 | $0 |
| 67028 | Injection of drug into eye | 1,227 | 264 | $0 |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,116 | 41 | $0 |
| J7999 | Compounded drug, not otherwise classified | 852 | 177 | $0 |
Insurance plans in this area (ZIP 97221)
Loading plans...
Provider's Procedures
Group practice members
| Name | Specialty | State |
|---|---|---|
| O P H T H A L M O L O G Y | OR | |
| - | OR | |
| O P H T H A L M O L O G Y | WA | |
| - | OR | |
| O P H T H A L M O L O G Y | OR | |
| O P H T H A L M O L O G Y | OR | |
| O P H T H A L M O L O G Y | NC |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.